Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Woojung Bio Inc. (215380:KRX), powered by AI.
Woojung Bio Inc. is currently trading at ₩2,470. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Woojung Bio Inc. on Alpha Lenz.
Woojung Bio Inc.'s P/E ratio is -7.5.
“Woojung Bio Inc. trades at a P/E of -7.5 (undervalued) with modest ROE of -21.0%.”
Ask for details →Woojung Bio Inc. is an esteemed entity within the biotechnology sector, known for its contributions to the development and innovation of healthcare solutions. Primarily, the company engages in the research, production, and distribution of various biopharmaceutical products focused on improving public health outcomes. With a robust portfolio that may include therapeutic drugs, diagnostic kits, and medical devices, Woojung Bio Inc. influences several aspects of the healthcare industry, aiding in the treatment and prevention of diseases. Its operations significantly impact related sectors, such as pharmaceuticals and clinical diagnostics, reinforcing its role as a vital player in the biotechnology market. By leveraging scientific research and cutting-edge technology, Woojung Bio Inc. aims to provide advanced medical solutions, thereby enhancing the quality of life and promoting well-being across global communities.
“Woojung Bio Inc. trades at a P/E of -7.5 (undervalued) with modest ROE of -21.0%.”
Ask for details →Woojung Bio Inc. (ticker: 215380) is a company listed on KRX in the Healthcare sector (Biotechnology). Market cap is $41.6B.
The current price is ₩2,470 with a P/E ratio of -7.49x and P/B of 1.78x.
ROE is -21.03% and operating margin is -9.72%. Annual revenue is $37.6B.